Brian Stoffel

TMFCheesehead

Brian Stoffel has been a Fool since 2008, and a financial journalist for The Motley Fool since 2010. He tends to follow the investment strategies of Fool co-founder David Gardner, looking for the most innovative companies driving positive change for the future. He also mixes in risk-management strategies he's learned from Nassim Nicholas Taleb.

HOW THE MOTLEY FOOL CAN HELP YOU

Motley Fool Returns

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns

393%

S&P 500 Returns

114%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/24/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Join Stock Advisor

Cumulative Growth of a $10,000 Investment in Stock Advisor

Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services

Brian Stoffel

Recent Articles by Brian Stoffel

5 Top Stocks for May

This Pandemic Stock Is Down Big From Its Highs, but Growth Isn't Slowing

This Global Tech Titan Is Wildly Undervalued

The Next Lululemon? A Profitable, Small-Cap Stock With Huge Potential

Why Lucid's Moat Isn't As Wide as Tesla's Was a Decade Ago

A Profitable High-Growth Stock With a $21.5 Billion Opportunity

Will This Be the Year Jumia Becomes "The Next Mercadolibre"?

A 10-Bagger in 2 Years? What You Need to Know About This Medical Device Stock

Why This Investor Likes Axon Enterprise Stock

This Global FinTech Is Down 45%. Does That Make It a Buy?

Here's What 2 Investors Think of Rivian and Its Stock

The Explosive Growth Stock That's Quietly Up 200% in the Past Year

Down 40% This Month Alone, Is This SaaS Stock a Screaming Buy?

This IPO Stock Has Potential for Multibagger Returns

Should You Put Your Next $1,000 Into This Healthcare IPO?

An Investors Look at SEMrush

Here's Why Affirm Stock Has Been Such a Great Investment. But Is It a Buy Today?

How I Turned $400 Into $15,000 ... and How I Plan to Do It Again

This Popular App Is Totally Free. Here's Why The Company Might Still Be a Good Investment

Can Open Lending Capitalize on AI the Same Way Upstart Did?

Invest Smarter with The Motley Fool

Join Over Half a Million Premium Members Receiving…

HOW THE MOTLEY FOOL CAN HELP YOU

Motley Fool Returns